fda warning letters compounded semaglutide tirzepatide september 2025 and Novo Nordisk Warned of GLP-1 Telehealth Compounding Takedown. What's Next? FDA Drug Recalls and Warnings:

2024 Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity

This exploratory, cross-sectional finding suggests a distinct role of oxidative stress in migraine pathophysiology

As such, insurers may not capture the full economic benefit of improved mortality

The safest, most effective alternative is clinically supervised dosing based on your health, goals, and response

STC-1 cells, in The impact of food bioactives on health:

Semaglutide is a research-backed medication proven to help manage weight and control blood sugar effectively